2023 Volume 63 Issue 7 Pages 109-113
The novel coronavirus disease (COVID-19) is not only a respiratory illness but also predisposes to cardiovascular diseases such as thromboses, strokes, myocardial infarctions, and arrhythmias due to infection of vascular endothelial cells and cytokine storm in the whole body. Cardiovascular disease, as an underlying condition, worsens the prognosis of COVID-19 and has a significant impact on the system of care. In addition, the increased risk of developing cardiovascular disease after sequelae and infection, referred to as Long COVID, is problematic.